Stoke Therapeutics, Inc. STOK Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s capital investments accrued but not yet paid?
- Stoke Therapeutics, Inc. (STOK) reported capital investments accrued but not yet paid of $334K in Q1 2026.
- How has Stoke Therapeutics, Inc.'s capital investments accrued but not yet paid changed year-over-year?
- Stoke Therapeutics, Inc.'s capital investments accrued but not yet paid increased by 1137.0% year-over-year, from $27K to $334K.